437 related articles for article (PubMed ID: 28352611)
1. Targeting the Metabolic Reprogramming That Controls Epithelial-to-Mesenchymal Transition in Aggressive Tumors.
Morandi A; Taddei ML; Chiarugi P; Giannoni E
Front Oncol; 2017; 7():40. PubMed ID: 28352611
[TBL] [Abstract][Full Text] [Related]
2. Epithelial-Mesenchymal Transition and Metabolic Switching in Cancer: Lessons From Somatic Cell Reprogramming.
Lai X; Li Q; Wu F; Lin J; Chen J; Zheng H; Guo L
Front Cell Dev Biol; 2020; 8():760. PubMed ID: 32850862
[TBL] [Abstract][Full Text] [Related]
3. Epithelial-mesenchymal transition in human cancer: comprehensive reprogramming of metabolism, epigenetics, and differentiation.
Li L; Li W
Pharmacol Ther; 2015 Jun; 150():33-46. PubMed ID: 25595324
[TBL] [Abstract][Full Text] [Related]
4. Epithelial-mesenchymal transition induces similar metabolic alterations in two independent breast cancer cell lines.
Kondaveeti Y; Guttilla Reed IK; White BA
Cancer Lett; 2015 Aug; 364(1):44-58. PubMed ID: 25917568
[TBL] [Abstract][Full Text] [Related]
5. Metabolic Reprogramming and Epithelial-Mesenchymal Plasticity: Opportunities and Challenges for Cancer Therapy.
Sun NY; Yang MH
Front Oncol; 2020; 10():792. PubMed ID: 32509584
[TBL] [Abstract][Full Text] [Related]
6. Metabolic Regulation of Epithelial to Mesenchymal Transition: Implications for Endocrine Cancer.
Bhattacharya D; Scimè A
Front Endocrinol (Lausanne); 2019; 10():773. PubMed ID: 31849832
[TBL] [Abstract][Full Text] [Related]
7. Potential role of NDRG2 in reprogramming cancer metabolism and epithelial-to-mesenchymal transition.
Chen XL; Lei L; Hong LL; Ling ZQ
Histol Histopathol; 2018 Jul; 33(7):655-663. PubMed ID: 29285747
[TBL] [Abstract][Full Text] [Related]
8. Metabolic Reprogramming and Dependencies Associated with Epithelial Cancer Stem Cells Independent of the Epithelial-Mesenchymal Transition Program.
Aguilar E; Marin de Mas I; Zodda E; Marin S; Morrish F; Selivanov V; Meca-Cortés Ó; Delowar H; Pons M; Izquierdo I; Celià-Terrassa T; de Atauri P; Centelles JJ; Hockenbery D; Thomson TM; Cascante M
Stem Cells; 2016 May; 34(5):1163-76. PubMed ID: 27146024
[TBL] [Abstract][Full Text] [Related]
9. Role of Metabolic Reprogramming in Epithelial⁻Mesenchymal Transition (EMT).
Kang H; Kim H; Lee S; Youn H; Youn B
Int J Mol Sci; 2019 Apr; 20(8):. PubMed ID: 31027222
[TBL] [Abstract][Full Text] [Related]
10. Pan-Cancer Analysis Reveals Distinct Metabolic Reprogramming in Different Epithelial-Mesenchymal Transition Activity States.
Sung JY; Cheong JH
Cancers (Basel); 2021 Apr; 13(8):. PubMed ID: 33917859
[TBL] [Abstract][Full Text] [Related]
11. Epithelial-to-Mesenchymal Transition: Epigenetic Reprogramming Driving Cellular Plasticity.
Skrypek N; Goossens S; De Smedt E; Vandamme N; Berx G
Trends Genet; 2017 Dec; 33(12):943-959. PubMed ID: 28919019
[TBL] [Abstract][Full Text] [Related]
12. EMT Factors and Metabolic Pathways in Cancer.
Georgakopoulos-Soares I; Chartoumpekis DV; Kyriazopoulou V; Zaravinos A
Front Oncol; 2020; 10():499. PubMed ID: 32318352
[TBL] [Abstract][Full Text] [Related]
13. Epithelial-mesenchymal transition (EMT): A biological process in the development, stem cell differentiation, and tumorigenesis.
Chen T; You Y; Jiang H; Wang ZZ
J Cell Physiol; 2017 Dec; 232(12):3261-3272. PubMed ID: 28079253
[TBL] [Abstract][Full Text] [Related]
14. Exploring the Metabolic Vulnerabilities of Epithelial-Mesenchymal Transition in Breast Cancer.
Sun X; Wang M; Wang M; Yao L; Li X; Dong H; Li M; Li X; Liu X; Xu Y
Front Cell Dev Biol; 2020; 8():655. PubMed ID: 32793598
[TBL] [Abstract][Full Text] [Related]
15. Therapeutic implications of cancer epithelial-mesenchymal transition (EMT).
Cho ES; Kang HE; Kim NH; Yook JI
Arch Pharm Res; 2019 Jan; 42(1):14-24. PubMed ID: 30649699
[TBL] [Abstract][Full Text] [Related]
16. Incomplete cellular reprogramming of colorectal cancer cells elicits an epithelial/mesenchymal hybrid phenotype.
Hiew MSY; Cheng HP; Huang CJ; Chong KY; Cheong SK; Choo KB; Kamarul T
J Biomed Sci; 2018 Jul; 25(1):57. PubMed ID: 30025541
[TBL] [Abstract][Full Text] [Related]
17. Catabolic metabolism during cancer EMT.
Cha YH; Yook JI; Kim HS; Kim NH
Arch Pharm Res; 2015 Mar; 38(3):313-20. PubMed ID: 25634102
[TBL] [Abstract][Full Text] [Related]
18. Epithelial-mesenchymal transition induction is associated with augmented glucose uptake and lactate production in pancreatic ductal adenocarcinoma.
Liu M; Quek LE; Sultani G; Turner N
Cancer Metab; 2016; 4():19. PubMed ID: 27777765
[TBL] [Abstract][Full Text] [Related]
19. Epigenetic reprogramming of epithelial mesenchymal transition in triple negative breast cancer cells with DNA methyltransferase and histone deacetylase inhibitors.
Su Y; Hopfinger NR; Nguyen TD; Pogash TJ; Santucci-Pereira J; Russo J
J Exp Clin Cancer Res; 2018 Dec; 37(1):314. PubMed ID: 30547810
[TBL] [Abstract][Full Text] [Related]
20. EMT- and MET-related processes in nonepithelial tumors: importance for disease progression, prognosis, and therapeutic opportunities.
Kahlert UD; Joseph JV; Kruyt FAE
Mol Oncol; 2017 Jul; 11(7):860-877. PubMed ID: 28556516
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
